60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis 60 Degrees Pharma (Nasdaq: SXTP) will sponsor a study using tafenoquine, an FDA-approved malaria drug, to treat canine babesiosis, a tick-borne disease.

Logo Brands and NC State Enter Exclusive Licensing Agreement for Branded Tailgate Supplies and Outdoor Products FRANKLIN, Tenn., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Logo Brands, Inc. has struck a strategic three-year licensing agreement with North Carolina State University, effective July 1, 2022. The...

Karamedica Announces National Institute on Aging Grant to Continue Development of Microparticle Therapy for Cerebral Amyloid Angiopathy RALEIGH, N.C., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Karamedica, Inc. recently received a $2.5 million Small Business Innovative Research (SBIR) Phase II grant from the National Institute on Aging to...

Draganfly Opens New Strategic United States Office on North Carolina State University’s Centennial Campus Vancouver, British Columbia, Feb. 11, 2020 (GLOBE NEWSWIRE) -- Draganfly Inc. (CSE: DFLY) (OTCQB: DFLYF) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer...

AGL Report: U.S. CEOs Focusing on Supply Chain Agility to Meet Rising Customer Expectations ATLANTA, July 09, 2019 (GLOBE NEWSWIRE) -- A new report from Logistics Trends & Insights and American Global Logistics (AGL)—“Adapting to the Age of the Consumer with an Agile Supply...